98 related articles for article (PubMed ID: 32761510)
1. High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.
Chen C; Peng S; Li P; Ma L; Gan X
Mol Cell Biochem; 2020 Dec; 475(1-2):15-25. PubMed ID: 32761510
[TBL] [Abstract][Full Text] [Related]
2. DRD1 suppresses cell proliferation and reduces EGFR activation and PD-L1 expression in NSCLC.
Grant CE; Flis AL; Toulabi L; Zingone A; Rossi E; Aploks K; Sheppard H; Ryan BM
Mol Oncol; 2024 Jun; 18(6):1631-1648. PubMed ID: 38572507
[TBL] [Abstract][Full Text] [Related]
3. Tenovin 3 induces apoptosis and ferroptosis in EGFR 19del non small cell lung cancer cells.
Lv S; Pan Q; Lu W; Zhang W; Wang N; Huang L; Li L; Liu J; Ma J; Li Z; Huang Y; Deng Q; Lei X
Sci Rep; 2024 Apr; 14(1):7654. PubMed ID: 38561419
[TBL] [Abstract][Full Text] [Related]
4. E2F1-mediated repression of WNT5A expression promotes brain metastasis dependent on the ERK1/2 pathway in EGFR-mutant non-small cell lung cancer.
Li H; Tong F; Meng R; Peng L; Wang J; Zhang R; Dong X
Cell Mol Life Sci; 2021 Mar; 78(6):2877-2891. PubMed ID: 33078208
[TBL] [Abstract][Full Text] [Related]
5. NEK2 promotes the progression of liver cancer by resisting the cellular senescence.
Lei Q; Xia J; Feng X; Guo J; Li G; Zhou W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Feb; 47(2):153-164. PubMed ID: 35545405
[TBL] [Abstract][Full Text] [Related]
6. Epidermal Growth Factor Receptor Expression and Resistance Patterns to Targeted Therapy in Non-Small Cell Lung Cancer: A Review.
Karlsen EA; Kahler S; Tefay J; Joseph SR; Simpson F
Cells; 2021 May; 10(5):. PubMed ID: 34069119
[TBL] [Abstract][Full Text] [Related]
7. Rare epidermal growth factor receptor (EGFR) mutations in non-small cell lung cancer.
Harrison PT; Vyse S; Huang PH
Semin Cancer Biol; 2020 Apr; 61():167-179. PubMed ID: 31562956
[TBL] [Abstract][Full Text] [Related]
8. Proscillaridin A induces apoptosis and suppresses non-small-cell lung cancer tumor growth via calcium-induced DR4 upregulation.
Li RZ; Fan XX; Duan FG; Jiang ZB; Pan HD; Luo LX; Zhou YL; Li Y; Yao YJ; Yao XJ; Leung EL; Liu L
Cell Death Dis; 2018 Jun; 9(6):696. PubMed ID: 29899551
[TBL] [Abstract][Full Text] [Related]
9. Depression and inflammation among epidermal growth factor receptor (EGFR) mutant nonsmall cell lung cancer patients.
McFarland DC; Jutagir DR; Rosenfeld B; Pirl W; Miller AH; Breitbart W; Nelson C
Psychooncology; 2019 Jul; 28(7):1461-1469. PubMed ID: 31022775
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional Inhibitor Reveals NEK2 as a Therapeutic Target and Regulator of Oncogenic Pathways in Lymphoma.
McCrury M; Swafford K; Shuttleworth SL; Mehdi SH; Acharya B; Saha D; Naceanceno K; Byrum SD; Storey AJ; Xu YZ; Doshier C; Patel V; Post GR; De Loose A; Rodriguez A; Shultz LD; Zhan F; Yoon D; Frett B; Kendrick S
Mol Cancer Ther; 2024 Mar; 23(3):316-329. PubMed ID: 37816504
[TBL] [Abstract][Full Text] [Related]
11. Litchi seed extract inhibits epidermal growth factor receptor signaling and growth of Two Non-small cell lung carcinoma cells.
Chung YC; Chen CH; Tsai YT; Lin CC; Chou JC; Kao TY; Huang CC; Cheng CH; Hsu CP
BMC Complement Altern Med; 2017 Jan; 17(1):16. PubMed ID: 28056952
[TBL] [Abstract][Full Text] [Related]
12. Role of long non-coding RNA in drug resistance in non-small cell lung cancer.
Wang L; Ma L; Xu F; Zhai W; Dong S; Yin L; Liu J; Yu Z
Thorac Cancer; 2018 Jul; 9(7):761-768. PubMed ID: 29726094
[TBL] [Abstract][Full Text] [Related]
13. Increased prevalence of EGFR-mutant lung cancer in women and in East Asian populations: analysis of estrogen-related polymorphisms.
Bell DW; Brannigan BW; Matsuo K; Finkelstein DM; Sordella R; Settleman J; Mitsudomi T; Haber DA
Clin Cancer Res; 2008 Jul; 14(13):4079-84. PubMed ID: 18593984
[TBL] [Abstract][Full Text] [Related]
14. Destabilizing NEK2 overcomes resistance to proteasome inhibition in multiple myeloma.
Franqui-Machin R; Hao M; Bai H; Gu Z; Zhan X; Habelhah H; Jethava Y; Qiu L; Frech I; Tricot G; Zhan F
J Clin Invest; 2018 Jul; 128(7):2877-2893. PubMed ID: 29863498
[TBL] [Abstract][Full Text] [Related]
15. Schizandrin A induces non-small cell lung cancer apoptosis by suppressing the epidermal growth factor receptor activation.
Zhu L; Wang Y; Huang X; Liu X; Ye B; He Y; Yu H; Lv W; Wang L; Hu J
Cancer Med; 2024 Jan; 13(2):e6942. PubMed ID: 38376003
[TBL] [Abstract][Full Text] [Related]
16. Treatment-Induced Tumor Dormancy through YAP-Mediated Transcriptional Reprogramming of the Apoptotic Pathway.
Kurppa KJ; Liu Y; To C; Zhang T; Fan M; Vajdi A; Knelson EH; Xie Y; Lim K; Cejas P; Portell A; Lizotte PH; Ficarro SB; Li S; Chen T; Haikala HM; Wang H; Bahcall M; Gao Y; Shalhout S; Boettcher S; Shin BH; Thai T; Wilkens MK; Tillgren ML; Mushajiang M; Xu M; Choi J; Bertram AA; Ebert BL; Beroukhim R; Bandopadhayay P; Awad MM; Gokhale PC; Kirschmeier PT; Marto JA; Camargo FD; Haq R; Paweletz CP; Wong KK; Barbie DA; Long HW; Gray NS; Jänne PA
Cancer Cell; 2020 Jan; 37(1):104-122.e12. PubMed ID: 31935369
[TBL] [Abstract][Full Text] [Related]
17. Nek2 Kinase Signaling in Malaria, Bone, Immune and Kidney Disorders to Metastatic Cancers and Drug Resistance: Progress on Nek2 Inhibitor Development.
Dana D; Das T; Choi A; Bhuiyan AI; Das TK; Talele TT; Pathak SK
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056661
[TBL] [Abstract][Full Text] [Related]
18.
Hofman P
Cells; 2021 Aug; 10(8):. PubMed ID: 34440926
[TBL] [Abstract][Full Text] [Related]
19. Exosomes: a new perspective in EGFR-mutated lung cancer.
Jouida A; McCarthy C; Fabre A; Keane MP
Cancer Metastasis Rev; 2021 Jun; 40(2):589-601. PubMed ID: 33855679
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanisms contributing to resistance to tyrosine kinase-targeted therapy for non-small cell lung cancer.
Nurwidya F; Murakami A; Takahashi F; Takahashi K
Cancer Biol Med; 2012 Mar; 9(1):18-22. PubMed ID: 23691449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
